Gilead Sciences, Inc.
YEZTUGO Text Terms & Conditions
These terms and conditions (“Terms & Conditions”) apply to individuals who have consented to receive text message communications from Gilead Sciences, Inc., business units, and its agents, including service providers on its behalf (collectively, “Gilead”) as part of enrollment in Gilead’s YEZTUGO Text Program (“YEZTUGO Text Program”).
- By opting in to receive text messages, you have consented to receive automated text message communications from Short Code 87072, from Gilead for updates, reminders, and information connected to the YEZTUGO Text Program.
- You are not required to consent to receive text messages to participate in the YEZTUGO Text Program, purchase any goods or services, or to receive any other communications you have selected.
- You can opt out of receiving texts from Gilead’s YEZTUGO Text Program by replying “STOP” to any message at any time. Doing so will only opt you out of this YEZTUGO Text Program; you will remain opted in to any other Gilead text message program(s) into which you opted separately. An unsubscribe message will be sent to your mobile number confirming the cancellation, but no more messages will be sent after that one.
- You can text “HELP” to 87072 in response to any message to receive help.
- You represent that you are the account holder for the mobile telephone number(s) that you provide to opt into the YEZTUGO Text Program. You are responsible for notifying Gilead immediately if you change your mobile telephone number.
- The number of text messages you receive will vary in frequency. There is no fee payable to Gilead to receive text messages; however, your carrier’s message and data rates may apply. Mobile carriers are not liable for delayed or undelivered messages.
- Data obtained from you in connection with the YEZTUGO Text Program may include your telephone number, your carrier’s name, and details of the message (date, time, and content). Gilead may use this information to contact you and to provide the services you request. Any data that Gilead may collect from you in connection with the YEZTUGO Text Program will be handled in accordance with the Gilead Privacy Policy, available at https://www.gilead.com/privacy-statement.
- No mobile information will be shared with third parties or affiliates for marketing or promotional purposes. Information sharing to subcontractors in support services, such as customer service, is permitted. All other use case categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties.
- Gilead cannot guarantee the successful delivery of text messages. Factors beyond the control of Gilead may impact message delivery, including equipment range and functionality, network capacity, terrain, proximity to buildings, foliage, and weather. Neither Gilead nor your mobile service provider carrier will be held liable for delayed or undelivered messages.
- The YEZTUGO Text Program is available on US participating mobile carriers.
- Gilead may immediately suspend or terminate your participation in the YEZTUGO Text Program if it believes you are in breach of these Terms & Conditions. Your participation in this YEZTUGO Text Program is also subject to termination in the event that your mobile telephone service terminates or lapses. Gilead reserves the right to modify or discontinue, temporarily or permanently, all or any part of the YEZTUGO Text Program, with or without notice.
- Gilead may revise, modify, or amend these Terms & Conditions at any time. Any such revision, modification, or amendment shall take effect when it is posted to Gilead’s website. You agree to review these Terms & Conditions periodically to ensure that you are aware of any changes. Your continued consent to receive text messages will indicate your acceptance of those changes.
YEZTUGO is a prescription medicine used to reduce the risk of getting HIV-1 in adults and adolescents who weigh at least 77 pounds. You must be HIV negative before and while receiving YEZTUGO.
YEZTUGO is a prescription medicine used to reduce the risk of getting HIV-1 in adults and adolescents who weigh at least 77 pounds. You must be HIV negative before and while receiving YEZTUGO.
Important Safety Information
What is the most important information I should know about YEZTUGO?
Before and while receiving YEZTUGO:
Tap for Important Safety Information, including an important warning on the risk of drug resistance if you become HIV positive and only take YEZTUGO.
- You must be HIV negative before you start and while receiving YEZTUGO. Get an HIV test before starting, before each injection, and when your healthcare provider tells you. If you think you were exposed to HIV while receiving YEZTUGO, talk to your healthcare provider as you may need an HIV test.
- Some HIV tests may not detect HIV in a person who recently acquired HIV. Tell your healthcare provider if you had a flu-like illness within the last month before starting or while receiving YEZTUGO. Symptoms of new HIV infection include tiredness, fever, joint or muscle aches, headache, sore throat, vomiting or diarrhea, rash, night sweats, and/or enlarged lymph nodes in the neck or groin.
- YEZTUGO does not prevent other sexually transmitted infections (STIs). Get tested for other STIs and practice safer sex by using condoms to reduce the risk of getting STIs.
- YEZTUGO is not approved to treat HIV. You must immediately take other medicines if you get HIV. If you have HIV and only receive YEZTUGO, your HIV may become harder to treat.
- Follow the YEZTUGO dosing schedule, which includes returning to a healthcare provider for your scheduled injections every 6 months. Missing scheduled injections or tablets can increase your chances of getting HIV.
- To further help reduce your risk of getting HIV:
- Know your HIV status and the HIV status of your partner(s). If they are living with HIV, your risk of getting HIV is lower if they are taking effective HIV treatment.
- Talk to your healthcare provider about all the ways to help reduce the risk of getting HIV.
Who should not receive or take YEZTUGO?
- Do not receive YEZTUGO if you already have HIV or do not know your HIV status. If you have HIV, you will need to take other medicines to treat it. YEZTUGO is not approved to treat HIV and is only for reducing the risk of getting HIV before you get it.
What are the possible side effects of YEZTUGO?
- The most common side effects of YEZTUGO are injection site reactions, headache, and nausea. These are not the only possible side effects.
- Reactions at the injection site may include a lump or bump, pain, skin hardening, swelling, itching, redness, bruising, or warmth.
- Rarely, if YEZTUGO is injected incorrectly by your healthcare provider, serious injection site reactions, like severe damage of the skin or open sores, can occur.
- Tell your healthcare provider if you have any injection site reactions or other side effects that bother you or don’t go away.
What should I tell my healthcare provider before receiving YEZTUGO?
- All your medical conditions.
- If you are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant while or after receiving YEZTUGO.
- If you are breastfeeding or plan to breastfeed. Talk to your healthcare provider about the best way to feed your baby while you are receiving YEZTUGO.
- All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. YEZTUGO can remain in your body for up to 9 months after your last injection and can affect other medicines. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Do not start a new medicine without telling your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
You are now leaving Yeztugo.com
Would you like to continue?